Skip to main content
Top

Calcified Tissue International

Issue 3/2023

Content (11 Articles)

Osteomalacia Original Research

Osteomalacia Prevalence, Biochemical Profile, and Histology in Patients with Low-Energy Hip Fractures Over the Age of 45

Peyman Mirghaderi, Ali Mortezaei, Joshua A. Parry, Maryam Salimi, Reza Mirghaderi, Alireza Moharrami, S. M. Javad Mortazavi

Open Access Scoliosis Original Research

Co-occurrence of Spondyloepiphyseal Dysplasia and X-Linked Hypophosphatemia in a Three-Generation Chinese Family

Jian Ma, Ye Zhang, Xiaoxiao Ding, Zhijiang Liang, Chaoxiang Yang, Zhi Deng, Hui He, Zhihong Guan, Chunhua Zeng, Yunting Lin, Xianqiong Luo

Systemic Mastocytosis Original Research

Assessment of Bone Microarchitecture in Patients with Systemic Mastocytosis and its Association with Clinical and Biochemical Parameters of the Disease

Andre S. Franco, Igor H. Murai, Liliam Takayama, Valeria F. Caparbo, Luan L. Marchi, Elvira D. R. P. Velloso, Rosa M. R. Pereira

Original Research

Functional Enrichment Analysis Identifying Regulatory Information Associated with Human Fracture

Xiang-He Meng, Zhen Liu, Xiang-Ding Chen, Ai-Min Deng, Zeng-Hui Mao

Open Access Computed Tomography Original Research

Association Between Hip Bone Mineral Density and Mortality Risk After Hip Fracture: A Prospective Cohort Study

Yufeng Ge, Yimin Chen, Gang Liu, Shiwen Zhu, Bo Li, Maoyi Tian, Jing Zhang, Xinbao Wu, Minghui Yang

Original Research

Alteration of Volumetric Bone Mineral Density Parameters in Men with Spinal Cord Injury

Laurent Maïmoun, Anthony Gelis, Chris Serrand, Thibault Mura, Ludovic Humbert, Vincent Boudousq, Pascal de Santa-Barbara, Didier Laux, Charles Fattal, Denis Mariano-Goulart

Open Access Computed Tomography Original Research

Distal Tibial Bone Properties and Bone Stress Injury Risk in Young Men Undergoing Arduous Physical Training

Katharine Eastman, Thomas J. O’Leary, Alexander Carswell, Neil Walsh, Rachel Izard, William Fraser, Julie Greeves

Osteoporosis Original Research

Zoledronate Promotes Peri-Implant Osteogenesis in Diabetic Osteoporosis by the AMPK Pathway

Yan Zhang, Shunyi Jia, Guochen Wen, Shanen Xie, Zhiqiang Song, Mengchun Qi, Yongqiang Liang, Wenjuan Bi, Wei Dong

Sarcopenia Letter to the Editor

Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know

Salomé Declerck, Guillaume Henin, Nicolas Lanthier

Open Access Sarcopenia Correction

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of

Aurélie Ladang, Charlotte Beaudart, Jean-Yves Reginster, Nasser Al-Daghri, Olivier Bruyère, Nansa Burlet, Matteo Cesari, Antonio Cherubini, Mario Coelho da Silva, Cyrus Cooper, Alfonso J. Cruz-Jentoft, Francesco Landi, Andrea Laslop, Stefania Maggi, Ali Mobasheri, Sif Ormarsdottir, Régis Radermecker, Marjolein Visser, Maria Concepcion Prieto Yerro, René Rizzoli, Etienne Cavalier

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine